文献速递肝病

自发性细菌性腹膜炎的白蛋白使用:诊疗差异、健康不平等与结局

Albumin for Spontaneous Bacterial Peritonitis: Care Variation, Disparities, and Outcomes.
PubMed 文献 · Am J Gastroenterol · 2024-11-12

该回顾性队列研究纳入2008至2021年退伍军人健康管理局中因自发性细菌性腹膜炎(SBP)住院的3,871例肝硬化患者,分析白蛋白使用趋势及相关因素。结果显示,20.7%未使用白蛋白,28.9%使用但未按指南,50.3%按指南使用;使用率从2008年的66%上升至2022年的88%。黑人退伍军人较白人更少接受指南推荐的白蛋白(OR 0.76,95%CI 0.59-0.98)。

要点

  • SBP住院肝硬化患者中,50.3%按指南使用白蛋白,20.7%未使用。
  • 黑人退伍军人较白人更少接受指南推荐的白蛋白(OR 0.76,95%CI 0.59-0.98)。
  • 胃肠/肝病或肾内科会诊与更高的指南推荐白蛋白使用相关。

核心结论

  • 在因SBP住院的退伍军人中,白蛋白使用随时间增加,但仍有相当比例未按指南使用,且存在种族差异;未来研究应优化白蛋白使用以减少差异并减轻医疗不平等。

研究设计与样本

  • 回顾性队列研究,纳入2008至2021年退伍军人健康管理局中因腹水标准确诊的SBP住院的肝硬化患者3,871例。

主要发现

  • 3,871例SBP退伍军人中,803例(20.7%)未接受白蛋白,1,119例(28.9%)接受白蛋白但未按指南,1,949例(50.3%)按指南接受白蛋白;使用率从2008年的66%上升至2022年的88%。
  • 黑人退伍军人较白人更少接受指南推荐的白蛋白(OR 0.76,95%CI 0.59-0.98)。
  • 与Child-Turcotte-Pugh A级相比,B级(OR 1.39,95%CI 1.17-1.64)和C级(OR 2.21,95%CI 1.61-3.04)更可能接受指南推荐的白蛋白。
  • 与无急性肾损伤相比,急性肾损伤1期(OR 1.48,95%CI 1.22-1.79)、2期(OR 2.17,95%CI 1.62-2.91)和3期(OR 1.68,95%CI 1.18-2.40)更可能接受指南推荐的白蛋白。
  • 胃肠/肝病会诊(OR 1.60,95%CI 1.29-1.99)、肾内科会诊(OR 1.60,95%CI 1.23-2.07)及两者同时会诊(OR 2.17,95%CI 1.60-2.96)与更高的白蛋白使用相关;在考虑MELD-Na与白蛋白交互作用的探索性分析中,指南推荐的白蛋白与更低的院内死亡率相关(HR 0.90,95%CI 0.85-0.96)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Intravenous albumin reduces mortality in spontaneous bacterial peritonitis (SBP). We sought to characterize albumin use for SBP over time and investigate patient-level and hospital-level factors associated with use. METHODS: A retrospective cohort study in the Veterans Health Administration between 2008 and 2021 evaluated trends and patient-level, practice-level, and facility-level factors associated with use among patients with cirrhosis hospitalized for SBP confirmed with ascitic fluid criteria. RESULTS: Among 3,871 veterans with SBP, 803 (20.7%) did not receive albumin, 1,119 (28.9%) received albumin but not per guidelines, and 1,949 (50.3%) received albumin per guidelines; use increased from 66% in 2008 to 88% in 2022. Veterans who identified as Black compared with White were less likely to receive guideline-recommended albumin (Odds ratio [OR] 0.76, 95% confidence interval [CI] 0.59-0.98) in all analyses. Guideline-recommended albumin was more likely to be administered to veterans with Child-Turcotte-Pugh class B (OR 1.39, 95% CI 1.17-1.64) and C (OR 2.21, 95% CI 1.61-3.04) compared with Child-Turcotte-Pugh A; and acute kidney injury Stage 1 (OR 1.48, 95% CI 1.22-1.79), Stage 2 (OR 2.17, 95% CI 1.62-2.91), and Stage 3 (OR 1.68, 95% CI 1.18-2.40) compared with no acute kidney injury. gastroenterology/hepatology consultation (OR 1.60, 95% CI 1.29-1.99), nephrology consultation (OR 1.60, 95% CI 1.23-2.07), and having both gastroenterology/hepatology and nephrology consultations (OR 2.17, 95% CI 1.60-2.96) were associated with higher albumin administration. In exploratory analyses accounting for interactions between model for end-stage liver disease sodium and albumin, guideline-recommended albumin was associated with lower in-hospital mortality (HR 0.90, 95% CI 0.85-0.96). DISCUSSION: Future studies should investigate optimizing albumin use for SBP to reduce the variability and mitigate healthcare disparities.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Serper M, Pulaski ME, Zhang S, et al. Albumin for Spontaneous Bacterial Peritonitis: Care Variation, Disparities, and Outcomes. Am J Gastroenterol. 2024. PMID: 39530516. doi:10.14309/ajg.0000000000003190

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。